These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 17643242)
1. In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans. Van Laere K Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1719-26. PubMed ID: 17643242 [No Abstract] [Full Text] [Related]
2. PET and SPECT in drug evaluation and drug design imaging inflammatory processes, tumors, and the endocannabinoid system. van Waarde A Curr Pharm Des; 2008; 14(31):3295-6. PubMed ID: 19075708 [No Abstract] [Full Text] [Related]
3. In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis. Goffin K; Van Paesschen W; Van Laere K Brain; 2011 Apr; 134(Pt 4):1033-40. PubMed ID: 21303859 [TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system in the brain: from biology to therapy. Maccarrone M Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):613. PubMed ID: 16375678 [No Abstract] [Full Text] [Related]
5. Has PET become an important clinical tool in paediatric imaging? Hahn K; Pfluger T Eur J Nucl Med Mol Imaging; 2004 May; 31(5):615-21. PubMed ID: 14762700 [No Abstract] [Full Text] [Related]
6. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome. Vemuri VK; Janero DR; Makriyannis A Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257 [TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid control of food intake and energy balance. Di Marzo V; Matias I Nat Neurosci; 2005 May; 8(5):585-9. PubMed ID: 15856067 [TBL] [Abstract][Full Text] [Related]
8. Molecular imaging update: advances in MI of the brain. VanBrocklin H; Herscovitch P J Nucl Med; 2007 May; 48(5):24N, 29N. PubMed ID: 17475948 [No Abstract] [Full Text] [Related]
9. Multiple sclerosis may disrupt endocannabinoid brain protection mechanism. Shohami E; Mechoulam R Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6087-8. PubMed ID: 16606822 [No Abstract] [Full Text] [Related]
12. Endocannabinoid overactivity and intestinal inflammation. Di Marzo V; Izzo AA Gut; 2006 Oct; 55(10):1373-6. PubMed ID: 16966693 [TBL] [Abstract][Full Text] [Related]
13. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629 [TBL] [Abstract][Full Text] [Related]
14. Primer on molecular imaging technology. Levin CS Eur J Nucl Med Mol Imaging; 2005 Dec; 32 Suppl 2():S325-45. PubMed ID: 16341514 [TBL] [Abstract][Full Text] [Related]
15. Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. González S; Valenti M; de Miguel R; Fezza F; Fernández-Ruiz J; Di Marzo V; Ramos JA Br J Pharmacol; 2004 Oct; 143(4):455-64. PubMed ID: 15371286 [TBL] [Abstract][Full Text] [Related]
16. Targeted lipidomics as a tool to investigate endocannabinoid function. Astarita G; Geaga J; Ahmed F; Piomelli D Int Rev Neurobiol; 2009; 85():35-55. PubMed ID: 19607960 [TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids in the dentate gyrus. Frazier CJ Prog Brain Res; 2007; 163():319-37. PubMed ID: 17765727 [TBL] [Abstract][Full Text] [Related]
18. Submillimetre spatial resolution is feasible in positron emission tomography. Schäfers KP; Schober O; Schäfers M Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):852-3. PubMed ID: 16703364 [No Abstract] [Full Text] [Related]